AGA Clinical Practice Update on Bariatric Surgery in Cirrhosis: Expert Review.
作者信息
Patton Heather, Heimbach Julie, McCullough Arthur
机构信息
Gastroenterology Section, VA San Diego Healthcare System, San Diego, California.
Division of Transplantation Surgery, Mayo Clinic College of Medicine, Rochester, Minnesota.
出版信息
Clin Gastroenterol Hepatol. 2021 Mar;19(3):436-445. doi: 10.1016/j.cgh.2020.10.034. Epub 2020 Oct 22.
Abstract
摘要
相似文献
1
AGA Clinical Practice Update on Bariatric Surgery in Cirrhosis: Expert Review.美国胃肠病学会关于肝硬化患者减肥手术的临床实践更新：专家综述
Clin Gastroenterol Hepatol. 2021 Mar;19(3):436-445. doi: 10.1016/j.cgh.2020.10.034. Epub 2020 Oct 22.
2
Outcomes of Bariatric Surgery in Patients with Liver Cirrhosis: a Systematic Review.肥胖症手术治疗肝硬化患者的效果：系统综述。
Obes Surg. 2021 May;31(5):2255-2267. doi: 10.1007/s11695-021-05289-x. Epub 2021 Feb 17.
3
AGA Clinical Practice Update on Evaluation and Management of Early Complications After Bariatric/Metabolic Surgery: Expert Review.AGA 临床实践更新：减重/代谢手术后早期并发症的评估和管理：专家综述。
Clin Gastroenterol Hepatol. 2021 Aug;19(8):1531-1537. doi: 10.1016/j.cgh.2021.03.020. Epub 2021 Mar 16.
4
A Systematic Review of Bariatric Surgery in Patients with Liver Cirrhosis.肝硬化患者减重手术的系统评价
Obes Surg. 2015 Aug;25(8):1518-26. doi: 10.1007/s11695-015-1727-2.
5
Considerations for bariatric surgery in patients with cirrhosis.肝硬化患者行减重手术的相关考虑。
World J Gastroenterol. 2018 Jul 28;24(28):3112-3119. doi: 10.3748/wjg.v24.i28.3112.
6
Outcomes of Bariatric Surgery in Patients with Cirrhosis.肥胖症患者的减肥手术结果。
Obes Surg. 2019 Feb;29(2):585-592. doi: 10.1007/s11695-018-3562-8.
7
The Effect of Bariatric Surgery on the Spectrum of Fatty Liver Disease.减重手术对脂肪性肝病谱的影响。
Can J Gastroenterol Hepatol. 2016;2016:2059245. doi: 10.1155/2016/2059245. Epub 2016 Sep 29.
8
Bariatric Surgery in Cirrhotic Patients: Is It Safe?肝硬化患者的减重手术：安全吗？
Obes Surg. 2020 Apr;30(4):1241-1248. doi: 10.1007/s11695-019-04214-7.
9
Bariatric Surgery is Effective and Safe for Obese Patients with Compensated Cirrhosis: A Systematic Review and Meta-Analysis.肥胖合并代偿期肝硬化患者行减重手术安全有效：系统评价和荟萃分析
World J Surg. 2022 May;46(5):1122-1133. doi: 10.1007/s00268-021-06382-z. Epub 2022 Mar 11.
10
Bariatric surgery in patients with liver cirrhosis.肝硬化患者的减重手术。
Surg Obes Relat Dis. 2013 Jan-Feb;9(1):1-6. doi: 10.1016/j.soard.2012.07.021. Epub 2012 Sep 11.
引用本文的文献
1
High MELD 3.0 score is not an absolute contraindication to bariatric surgery.高MELD 3.0评分并非减重手术的绝对禁忌证。
Surg Endosc. 2025 Aug 6. doi: 10.1007/s00464-025-11940-w.
2
Pathological Evolution and Internal Medicine Management of Nonalcoholic Fatty Liver Disease (NAFLD) in the Era of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).代谢功能障碍相关脂肪性肝病（MASLD）时代非酒精性脂肪性肝病（NAFLD）的病理演变与内科管理
Cureus. 2025 Jun 29;17(6):e86963. doi: 10.7759/cureus.86963. eCollection 2025 Jun.
3
Is Bariatric Surgery Safe to Perform in Patients with Chronic Liver Disease? A National Cross-Sectional Study.对慢性肝病患者实施减重手术是否安全？一项全国性横断面研究。
Obes Surg. 2025 Jun;35(6):2264-2273. doi: 10.1007/s11695-025-07926-1. Epub 2025 May 17.
4
Survival and Cost-Effectiveness of Bariatric Surgery Among Patients With Obesity and Cirrhosis.肥胖与肝硬化患者接受减重手术的生存率及成本效益
JAMA Surg. 2025 Jun 1;160(6):645-655. doi: 10.1001/jamasurg.2025.0490.
5
The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease.亚太肝脏研究协会代谢功能障碍相关脂肪性肝病诊断和管理临床实践指南
Hepatol Int. 2025 Apr;19(2):261-301. doi: 10.1007/s12072-024-10774-3. Epub 2025 Feb 27.
6
Impact of Weight Loss on Metabolic Dysfunction Associated Steatohepatitis and Hepatic Fibrosis.体重减轻对代谢功能障碍相关脂肪性肝炎和肝纤维化的影响。
Curr Diab Rep. 2025 Feb 18;25(1):23. doi: 10.1007/s11892-025-01579-1.
7
Transjugular Intrahepatic Portosystemic Shunt (TIPS): A Bridge to Bariatric Surgery in Morbidly Obese Patients with Cirrhosis and Clinically Significant Portal Hypertension.经颈静脉肝内门体分流术（TIPS）：肥胖症合并肝硬化及具有临床意义的门静脉高压症患者进行减重手术的桥梁
Obes Surg. 2025 Feb;35(2):395-405. doi: 10.1007/s11695-024-07583-w. Epub 2024 Dec 29.
8
A leap in the dark: Bariatric surgery for treatment of metabolic dysfunction-associated steatotic liver disease related cirrhosis: Editorial on "Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis".在黑暗中迈出的一步：减重手术治疗代谢功能障碍相关脂肪性肝病相关性肝硬化：关于“减重手术降低代谢功能障碍相关脂肪性肝病和肝硬化患者的长期死亡率”的社论
Clin Mol Hepatol. 2025 Apr;31(2):610-614. doi: 10.3350/cmh.2024.1099. Epub 2024 Dec 17.
9
MGB-OAGB International Club-Results of a Modified Delphi Consensus on Controversies in OAGB.MGB-OAGB国际俱乐部——关于OAGB争议的改良德尔菲共识结果
Obes Surg. 2024 Dec;34(12):4541-4554. doi: 10.1007/s11695-024-07563-0. Epub 2024 Nov 19.
10
Perioperative Risk in Patients With Cirrhosis.肝硬化患者的围手术期风险
Gastroenterol Hepatol (N Y). 2024 Aug;20(5):290-293.
本文引用的文献
1
Intragastric Balloon Placement Induces Significant Metabolic and Histologic Improvement in Patients With Nonalcoholic Steatohepatitis.胃内球囊放置术可显著改善非酒精性脂肪性肝炎患者的代谢和组织学状况。
Clin Gastroenterol Hepatol. 2021 Jan;19(1):146-154.e4. doi: 10.1016/j.cgh.2020.04.068. Epub 2020 Apr 30.
2
Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease: Evidence and perspectives.非酒精性脂肪性肝病的内镜减肥和代谢疗法：证据与展望。
Liver Int. 2020 Jun;40(6):1262-1268. doi: 10.1111/liv.14441. Epub 2020 Apr 6.
3
Post-transplant obesity impacts long-term survival after liver transplantation.肝移植后肥胖会影响长期生存。
Metabolism. 2020 May;106:154204. doi: 10.1016/j.metabol.2020.154204. Epub 2020 Mar 13.
4
Bariatric surgery is associated with reduction in non-alcoholic steatohepatitis and hepatocellular carcinoma: A propensity matched analysis.减重手术与非酒精性脂肪性肝炎和肝细胞癌的减少有关：一项倾向评分匹配分析。
Am J Surg. 2020 Mar;219(3):504-507. doi: 10.1016/j.amjsurg.2019.09.006. Epub 2019 Sep 16.
5
Mortality after bariatric surgery: findings from a 7-year multicenter cohort study.减重手术后的死亡率：一项为期 7 年的多中心队列研究结果。
Surg Obes Relat Dis. 2019 Oct;15(10):1755-1765. doi: 10.1016/j.soard.2019.08.015. Epub 2019 Aug 26.
6
Delayed Sleeve Gastrectomy Following Liver Transplantation: A 5-Year Experience.肝移植术后延迟袖状胃切除术：5 年经验。
Liver Transpl. 2019 Nov;25(11):1673-1681. doi: 10.1002/lt.25637. Epub 2019 Oct 15.
7
Obesity Is the Most Common Risk Factor for Chronic Liver Disease: Results From a Risk Stratification Pathway Using Transient Elastography.肥胖是慢性肝病最常见的危险因素：应用瞬时弹性成像的风险分层路径的结果。
Am J Gastroenterol. 2019 Nov;114(11):1744-1752. doi: 10.14309/ajg.0000000000000357.
8
Changes in Alcohol Use after Metabolic and Bariatric Surgery: Predictors and Mechanisms.代谢与减重手术后饮酒行为的变化：预测因子与机制
Curr Psychiatry Rep. 2019 Aug 13;21(9):85. doi: 10.1007/s11920-019-1070-8.
9
Obesity in acute alcoholic hepatitis increases morbidity and mortality.急性酒精性肝炎患者的肥胖会增加发病率和死亡率。
EBioMedicine. 2019 Jul;45:511-518. doi: 10.1016/j.ebiom.2019.03.046. Epub 2019 Jul 3.
10
A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation.北美专家关于肝移植中肌肉减少症的观点声明。
Hepatology. 2019 Nov;70(5):1816-1829. doi: 10.1002/hep.30828. Epub 2019 Aug 19.
Zotero 插件